Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：4.848 Date：2021-10-20

Frontiers in Oncology

Downregulation of hsa_circ_0001836 Induces Pyroptosis Cell Death in Glioma Cells via Epigenetically Upregulating NLRP1

Products： ELK1245、 ELK1270、 EQ003
IF：4.848 Date：2021-10-26

Frontiers in Oncology

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug

Products： EP013、 EQ001
IF：4.848 Date：2021-10-26

Frontiers in Oncology

Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway

Products： EQ001
IF：4.8 Date：2021-10-20

BIOMEDICINE & PHARMACOTHERAPY

Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats

Products： ELK1144、 ELK1158、 ELK1272、 ELK1396、 EP013

< Page of 389 >